HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonobstructive Azoospermia

Azoospermia that is caused by hereditary defects which disrupt sperm development before or during meiosis. Mutations and polymorphisms in the USP9Y (OMIM: 415000), SLC26A8 (OMIM: 606766), DAZL (OMIM: 601486), and SYCP3 (OMIM: 270960) have been identified.
Also Known As:
Azoospermia, Nonobstructive
Networked: 165 relevant articles (5 outcomes, 24 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Azoospermia
2. Oligospermia (Oligozoospermia)
3. Male Infertility (Male Sterility)
4. Sertoli Cell-Only Syndrome
5. Genetic Predisposition to Disease (Genetic Predisposition)

Experts

1. Schlegel, Peter N: 9 articles (01/2022 - 11/2002)
2. Fujisawa, Masato: 5 articles (11/2015 - 06/2008)
3. Chiba, Koji: 4 articles (11/2015 - 10/2009)
4. Ramasamy, Ranjith: 4 articles (10/2014 - 03/2011)
5. Yamaguchi, Kohei: 4 articles (11/2012 - 06/2008)
6. Li, Honggang: 3 articles (08/2021 - 10/2016)
7. Miyake, Hideaki: 3 articles (11/2015 - 07/2012)
8. Jarvi, Keith: 3 articles (11/2013 - 08/2009)
9. Lo, Kirk C: 3 articles (08/2009 - 01/2005)
10. Jørgensen, Niels: 2 articles (10/2022 - 01/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Nonobstructive Azoospermia:
1. inhibin BIBA
2. Messenger RNA (mRNA)IBA
3. LipidsIBA
4. Inositol (Myoinositol)IBA
5. Glucose (Dextrose)FDA LinkGeneric
6. Choline (Choline Chloride)IBA
7. Biomarkers (Surrogate Marker)IBA
8. Hormones (Hormone)IBA
9. Follicle Stimulating Hormone (Follitropin)FDA Link
10. Proteins (Proteins, Gene)FDA Link

Therapies and Procedures

1. Vasectomy (Vas Occlusion)
2. Therapeutics
3. Orchiectomy (Orchidectomy)
4. Drug Therapy (Chemotherapy)
5. Orchiopexy